Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
We observed a promising response on addition of immunotherapy to NAC among patients with MpBC, suggesting that immunotherapy may have great potential in the treatment of metaplastic breast carcinoma.
Authors
- Qingjian Tan (ORCID: https://orcid.org/0009-0004-9288-9026)
- Tian Du (ORCID: https://orcid.org/0000-0003-0841-6484)
- Hao Wu (ORCID: https://orcid.org/0000-0001-7097-0406)
- Zixuan Zhao (ORCID: https://orcid.org/0000-0001-7460-0074)
- Na Li (ORCID: https://orcid.org/0000-0003-1056-3264)
- Yan Wang (ORCID: https://orcid.org/0000-0001-8622-3480)
- Jun Tang (ORCID: https://orcid.org/0000-0002-9788-8389)
- Gehao Liang
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/bctt.s512790
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Natural Science Foundation of China